Digital Babies: Galway Scientists Crack Infant Health Code
Scientists at the University of Galway have pulled off a game-changing breakthrough in infant health. Using cutting-edge computer tech, they’ve created digital babies—models that mimic newborns’ unique metabolic processes during their crucial first 180 days.
Inside the Complex World of Baby Metabolism
The team built 360 whole-body computational models for both male and female infants. Each model includes 26 organs, six cell types, and over 80,000 metabolic reactions. They based these virtual babies on real data from 10,000 newborns, including sex, birth weight, and metabolite levels, ensuring high accuracy.
Lead author Elaine Zaunseder from Heidelberg University stresses, “Babies are not just small adults.” For example, newborns can’t shiver in their first six months, so their metabolism must generate heat to keep them warm.
How Computational Models Could Save Lives
The digital models map out how infants’ organs use energy—very differently from adults. By factoring in breast milk metabolism, the researchers simulated growth and energy use across the entire baby’s body. The result? Digital babies grew just like real ones over six months.
Professor Ines Thiele, study lead, champions personalised disease management. Newborn screening already detects metabolic diseases early, improving survival. But babies vary widely, so tailored treatments are key.
The models can replicate healthy metabolism and also mimic inherited metabolic disorders with striking accuracy, predicting known biomarkers. They reveal how different treatments impact metabolism, opening doors to precise, life-saving therapies.
The Future of Paediatric Healthcare: Digital Metabolic Twins
Elaine Zaunseder believes these digital metabolic twins mark a huge leap forward. They could revolutionise paediatric care by tailoring disease management to each infant’s unique metabolic needs.
The University of Galway’s Digital Metabolic Twin Centre, in partnership with Heidelberg University, hopes this pioneering research will transform diagnosis and treatment during a baby’s most vulnerable early days.